Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Completed Phase 1 Trials for 2'-Deoxycytidine (DB02594)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00357708Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other DiseasesTreatment